Abstract
A total of 22 relapsed or refractory ovarian cancer patients were treated with ifosfamide-containing polychemotherapy. Kinetic analyses were done to evaluate the tumor-cell-recruiting potential of the alkylating agent. Our study shows that ifosfamide can enhance tumor proliferative activity in pretreated ovarian cancers.
Original language | English |
---|---|
Journal | Cancer Chemotherapy and Pharmacology |
Volume | 26 |
Issue number | 1 Supplement |
DOIs | |
Publication status | Published - Jan 1990 |
ASJC Scopus subject areas
- Pharmacology
- Oncology
- Cancer Research